128 related articles for article (PubMed ID: 1662033)
1. [Effect of sinorphan, an endopeptidase inhibitor on severe congestive cardiac insufficiency].
Varin J; Duboc D; Weber S; Fouchard J; Schwartz JC; Muffat-Joly M; Guérin F
Arch Mal Coeur Vaiss; 1991 Oct; 84(10):1465-71. PubMed ID: 1662033
[TBL] [Abstract][Full Text] [Related]
2. Effect of sinorphan, an enkephalinase inhibitor, on plasma atrial natriuretic factor and sodium urinary excretion in cirrhotic patients with ascites.
Dussaule JC; Grangé JD; Wolf JP; Lecomte JM; Gros C; Schwartz JC; Bodin F; Ardaillou R
J Clin Endocrinol Metab; 1991 Mar; 72(3):653-9. PubMed ID: 1847706
[TBL] [Abstract][Full Text] [Related]
3. Acute inhibition of endopeptidase 24.11 in essential hypertension: SCH 34826 enhances atrial natriuretic peptide and natriuresis without lowering blood pressure.
Richards AM; Crozier IG; Espiner EA; Ikram H; Yandle TG; Kosoglou T; Rallings M; Frampton C
J Cardiovasc Pharmacol; 1992; 20(5):735-41. PubMed ID: 1280735
[TBL] [Abstract][Full Text] [Related]
4. Neutral endopeptidase versus angiotensin converting enzyme inhibition in essential hypertension.
Favrat B; Burnier M; Nussberger J; Lecomte JM; Brouard R; Waeber B; Brunner HR
J Hypertens; 1995 Jul; 13(7):797-804. PubMed ID: 7594444
[TBL] [Abstract][Full Text] [Related]
5. Effects of atrial natriuretic factor on natriuresis and cGMP in patients with essential hypertension.
Cusson JR; Hamet P; Gutkowska J; Kuchel O; Genest J; Cantin M; Larochelle P
J Hypertens; 1987 Aug; 5(4):435-43. PubMed ID: 2822796
[TBL] [Abstract][Full Text] [Related]
6. Effects of converting enzyme inhibitor and neutral endopeptidase inhibitor on blood pressure and renal function in experimental hypertension.
Pham I; Gonzalez W; el Amrani AI; Fournié-Zaluski MC; Philippe M; Laboulandine I; Roques BP; Michel JB
J Pharmacol Exp Ther; 1993 Jun; 265(3):1339-47. PubMed ID: 8389863
[TBL] [Abstract][Full Text] [Related]
7. [Effects of phenylephrine on atrial natriuretic factor and the renin-aldosterone axis in normal patients and essential hypertensive patients].
Closas J; Genest J; Larochelle P; Cusson J; Gutkowska J; Hamet P; De Léan A; Thibault G; Cantin M
Arch Mal Coeur Vaiss; 1988 Jun; 81 Spec No():75-8. PubMed ID: 2847676
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of neutral endopeptidase stimulates renal sodium excretion in patients with chronic renal failure.
Dussaule JC; Michel C; Peraldi MN; Lecomte JM; Gros C; Mignon F; Ardaillou R
Clin Sci (Lond); 1993 Jan; 84(1):31-9. PubMed ID: 8382131
[TBL] [Abstract][Full Text] [Related]
9. Effect of endopeptidase 24.11 inhibition in conscious cardiomyopathic hamsters.
Smits GJ; McGraw DE; Trapani AJ; Blaine EB
J Pharmacol Exp Ther; 1990 Jul; 254(1):176-9. PubMed ID: 2142219
[TBL] [Abstract][Full Text] [Related]
10. Stereoselective protection of exogenous and endogenous atrial natriuretic factor by enkephalinase inhibitors in mice and humans.
Lecomte JM; Baumer P; Lim C; Duchier J; Cournot A; Dussaule JC; Ardaillou R; Gros C; Chaignon B; Souque A
Eur J Pharmacol; 1990 Apr; 179(1-2):65-73. PubMed ID: 2163851
[TBL] [Abstract][Full Text] [Related]
11. Prolonged inhibition of neutral endopeptidase 24.11 by sinorphan in stroke-prone spontaneously hypertensive rats.
Stasch JP; Knorr A; Wegner M; Hirth-Dietrich C
Hypertens Res; 1995 Jun; 18(2):137-43. PubMed ID: 7584920
[TBL] [Abstract][Full Text] [Related]
12. [Hemodynamic and renal effects of synthetic atrial natriuretic factor (alpha-h-ANF) in patients with congestive heart failure].
Fontana F; Guardigli G; Cappelli M; Bernardi P
G Ital Cardiol; 1988 Jul; 18(7):567-77. PubMed ID: 2976692
[TBL] [Abstract][Full Text] [Related]
13. Atrial natriuretic factor after dopamine infusion in healthy subjects and in congestive heart failure.
Fontana F; Bernardi P; Ruffini M; Capelli M
Eur Heart J; 1991 Jul; 12(7):803-6. PubMed ID: 1832381
[TBL] [Abstract][Full Text] [Related]
14. Effects of alatriopril, a mixed inhibitor of atriopeptidase and angiotensin I-converting enzyme, on cardiac hypertrophy and hormonal responses in rats with myocardial infarction. Comparison with captopril.
Bralet J; Marie C; Mossiat C; Lecomte JM; Gros C; Schwartz JC
J Pharmacol Exp Ther; 1994 Jul; 270(1):8-14. PubMed ID: 8035346
[TBL] [Abstract][Full Text] [Related]
15. Prolonged inhibition of endopeptidase 24.11 in normal man: renal, endocrine and haemodynamic effects.
Richards AM; Wittert G; Espiner EA; Yandle TG; Frampton C; Ikram H
J Hypertens; 1991 Oct; 9(10):955-62. PubMed ID: 1658138
[TBL] [Abstract][Full Text] [Related]
16. Thiorphan-induced natriuresis in volume-expanded rats: roles of endogenous atrial natriuretic factor and kinins.
Bralet J; Mossiat C; Gros C; Schwartz JC
J Pharmacol Exp Ther; 1991 Sep; 258(3):807-11. PubMed ID: 1653839
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of the metabolism of atrial natriuretic factor causes diuresis and natriuresis in chronic heart failure.
Northridge DB; Jardine AG; Findlay IN; Archibald M; Dilly SG; Dargie HJ
Am J Hypertens; 1990 Sep; 3(9):682-7. PubMed ID: 2145874
[TBL] [Abstract][Full Text] [Related]
18. Renal tubular sensitivity to atrial natriuretic factor in essential hypertension.
Janssen WM; de Zeeuw D; van der Hem GK; de Jong PE
J Hypertens; 1994 Apr; 12(4):439-47. PubMed ID: 8064168
[TBL] [Abstract][Full Text] [Related]
19. [Atrial natriuretic factor, catecholamines and the renin-angiotensin system in cardiac insufficiency. Relation to hemodynamic parameters].
Komajda M; Carayon A; Nguyen JP; Maistre G; Drobinski G; Legrand S; Landault C; Legrand JC; Grosgogeat Y
Arch Mal Coeur Vaiss; 1988 Jul; 81(7):845-53. PubMed ID: 2973293
[TBL] [Abstract][Full Text] [Related]
20. Renal effects of brain natriuretic peptide in patients with congestive heart failure.
Jensen KT; Eiskjaer H; Carstens J; Pedersen EB
Clin Sci (Lond); 1999 Jan; 96(1):5-15. PubMed ID: 9857101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
